BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31578743)

  • 1. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms.
    Ohmori Y; Nomura T; Fukushima N; Takahashi F; Iwaya T; Koeda K; Nishizuka SS;
    J Surg Oncol; 2019 Dec; 120(7):1154-1161. PubMed ID: 31578743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
    Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.
    Wang S; Chen L; Zhao Q; Rong H; Wang M; Gong W; Zhou J; Wu D; Zhang Z
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):1073-82. PubMed ID: 23423487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
    Bansal A; Das P; Kannan S; Mahantshetty U; Mulherkar R
    Indian J Med Res; 2016 Sep; 144(3):359-365. PubMed ID: 28139534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced Gastric Cancer Patients.
    Zha Y; Gan P; Liu Q; Yao Q
    Arch Med Res; 2016 Jan; 47(1):13-8. PubMed ID: 26696550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
    Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
    Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma.
    Zhang ZW; Laurence NJ; Hollowood A; Newcomb P; Moorghen M; Gupta J; Feakins R; Farthing MJ; Alderson D; Holly J
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):131-5. PubMed ID: 14734461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
    Song HR; Kweon SS; Kim HN; Piao JM; Yun WJ; Choi JS; Hwang JE; Yoon JY; Kim HR; Park YK; Kim SH; Choi YD; Shin MH
    Gastric Cancer; 2011 Aug; 14(3):242-8. PubMed ID: 21461655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competing risk nomogram predicting initial loco-regional recurrence in gastric cancer patients after D2 gastrectomy.
    Wang SB; Qi WX; Chen JY; Xu C; Kirova YM; Cao WG; Cai R; Cao L; Yan M; Cai G
    Radiat Oncol; 2019 Jul; 14(1):128. PubMed ID: 31315683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
    Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
    Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
    Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
    Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.
    Liu KJ; Qi HZ; Yao HL; Lei SL; Lei ZD; Li TG; Zhao H
    Mol Biol Rep; 2012 Aug; 39(8):8265-75. PubMed ID: 22707142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
    Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
    Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer.
    Zhang Q; Ma YY; Wang HJ; Shao CM; Zhang J; Ye ZY
    J Surg Oncol; 2013 Mar; 107(4):360-6. PubMed ID: 22886602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There Any Role of Adjuvant Chemotherapy for T3N0M0 or T1N2M0 Gastric Cancer Patients in Stage II in the 7th TNM but Stage I in the 6th TNM System?
    Lee KG; Lee HJ; Oh SY; Yang JY; Ahn HS; Suh YS; Kong SH; Kim TY; Oh DY; Im SA; Lee KU; Kim WH; Bang YJ; Yang HK
    Ann Surg Oncol; 2016 Apr; 23(4):1234-43. PubMed ID: 26597366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.
    Pérez-Pérez GI; Bosques-Padilla FJ; Crosatti ML; Tijerina-Menchaca R; Garza-González E
    Scand J Gastroenterol; 2005 Jan; 40(1):56-60. PubMed ID: 15841715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.